Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies
Globe Newswire28-02-2023, 11:50
Crurated Raises $7.2 MM to Further Innovate Blockchain-Based Wine Community and Expand Market Reach 17-01-2023, 19:00